Literature DB >> 6358127

The pharmacology of calcium channel antagonists: a novel class of anti-migraine agents?

S J Peroutka.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6358127     DOI: 10.1111/j.1526-4610.1983.hed2306278.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


× No keyword cloud information.
  7 in total

1.  Migraine Prophylaxis: A pharmacologic approach.

Authors:  I Danys
Journal:  Can Fam Physician       Date:  1991-01       Impact factor: 3.275

Review 2.  Diltiazem. A review of its pharmacological properties and therapeutic efficacy.

Authors:  M Chaffman; R N Brogden
Journal:  Drugs       Date:  1985-05       Impact factor: 9.546

3.  Comparative efficacy of cyclandelate versus flunarizine in the prophylactic treatment of migraine.

Authors:  G Nappi; G Sandrini; G Savoini; A Cavallini; C de Rysky; G Micieli
Journal:  Drugs       Date:  1987       Impact factor: 9.546

4.  Nimodipine-induced changes in the distribution of carotid blood flow and cardiac output in pentobarbitone-anaesthetized pigs.

Authors:  D J Duncker; J Heiligers; E J Mylecharane; P R Saxena; P D Verdouw
Journal:  Br J Pharmacol       Date:  1986-09       Impact factor: 8.739

5.  Evidence for verapamil-induced functional inhibition of noradrenergic neurotransmission in vivo.

Authors:  S Gurtu; S Seth; A K Roychoudhary
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-02       Impact factor: 3.000

6.  Serum calcium and risk of migraine: a Mendelian randomization study.

Authors:  Peter Yin; Verneri Anttila; Katherine M Siewert; Aarno Palotie; George Davey Smith; Benjamin F Voight
Journal:  Hum Mol Genet       Date:  2017-02-15       Impact factor: 6.150

7.  Flunarizine suppresses endothelial Angiopoietin-2 in a calcium - dependent fashion in sepsis.

Authors:  Jennifer Retzlaff; Kristina Thamm; Chandra C Ghosh; Wolfgang Ziegler; Hermann Haller; Samir M Parikh; Sascha David
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.